Managing Stinging Insect Allergy in the 21st Century

2306

Saturday, March 5, 2016: 10:45 AM-12:00 PM

Convention Center, Level One, Petree Hall C

1.25 CME/CE

Symposium

Moderator:

Dennis K. Ledford , MD FAAAAI

Learning Objectives:

Describe the mechanism of tolerance development during venom immunotherapy
Assess the indications for initiation and discontinuation of venom immunotherapy
Evaluate the overlap between venom-induced anaphylaxis and mast cell disorders

This Session Will Use Audience Response System Technology.

10:45 AM

Mechanism of Tolerance to Venom Induced By Immunotherapy
Cezmi A. Akdis, MD FAAAAI

11:05 AM

Question & Answer

11:10 AM

Initiation and Discontinuation of Venom Immunotherapy: How Long is Enough?
David B.K. Golden, MD FAAAAI

Handouts

11:30 AM

Question & Answer

11:35 AM

Anaphylaxis after Hymenoptera Sting-Overlap with Mast Cell Disorder
Mariana C. Castells, MD PhD FAAAAI

11:55 AM

Question & Answer

See more of: Session